Coloplast A/S : - Transactions in connection with share buy-back programme, week 16

As mentioned in Announcement no. 02/2020 Coloplast is initiating a share buyback programme totalling up to DKK 500 million.

The programme will commence on 24 February 2020 and is expected to end by 24 August 2020.

The share buyback programme is carried out in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour Regulations with the purpose of meeting obligations arising from share options programmes or other allocation of shares to employees or to complete a share capital decrease as set out in Articles 5(2)(a) and 5(2)(c) in MAR.

The following transactions have been executed during the period 14 – 17 April 2020:

Date	Number of shares	Average purchase price, DKK	Transaction value, DKK
14 April 2020	500	1,014.65	507,325
15 April 2020	300	1,033.08	309,924
16 April 2020	400	1,058.45	423,380
17 April 2020	275	1,046.53	287,796
Accumulated until now under the programme	241,901	919.69	222,474,467

Henceforth, Coloplast owns 3,288,736 treasury B shares of DKK 1 equal to 1.52% of the company’s total share capital.

An overview showing the transaction data for the period 14 – 17 April 2020 is enclosed.

Kind regards,
Investor Relations
Coloplast A/S
Tel. [phone]

 

For further information, please contact
  
Investors and analysts
Ellen Bjurgert
Vice President, Investor Relations
Tel. [phone]
Email: [e-mail]

Rasmus Sørensen
Sr. Manager, Investor Relations
Tel. [phone]
Email: [e-mail]
                                                                                       
Press and the media
Lina Danstrup
Sr. Media Relations Manager
Tel. [phone]
Email: [e-mail]

Address
Coloplast A/S
Holtedam 1
DK-3050 Humlebaek
Danmark
CVR NR. 69749917

Website
www.coloplast.com

This announcement is available in a Danish and an English-language version. In the event of discrepancies, the Danish version shall prevail.

Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use our products, we create solutions that are sensitive to their special needs. We call this intimate healthcare. Our business includes Ostomy Care, Continence Care, Wound and Skin Care and Interventional Urology. We operate globally and employ about 12,000 employees.

The Coloplast logo is a registered trademark of Coloplast A/S. © 2020-04.
All rights reserved Coloplast A/S, 3050 Humlebaek, Denmark.

Attachments

• 2004020_Sharebuyback
• Transaction data_week16

© OMX, source OMX